Welcome to our dedicated page for Strive SEC filings (Ticker: ASST), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Strive, Inc. filings document the company’s structured finance and asset management business, bitcoin treasury operations, preferred stock structure, and public-company governance. Its 8-K reports disclose business updates such as bitcoin, cash, investment and capital stock balances, dividend actions for the Variable Rate Series A Perpetual Preferred Stock, and quarterly operating and financial results.
Strive’s SEC record also includes proxy materials for annual meeting matters, including auditor ratification, and disclosures identifying the company as a Nevada corporation and emerging growth company. Filing subjects include Class A and Class B common stock, SATA preferred stock, advisory activities through Strive Asset Management, LLC, forward-looking risk language, and material-event reporting tied to capital allocation and treasury strategy.
Strive, Inc. issued a Rule 425 communication about its proposed business combination with Semler Scientific, Inc. (SMLR). Strive has filed a Registration Statement on Form S‑4 to register the Class A common stock it would issue in the transaction, which will include an information statement of Strive, a proxy statement for Semler Scientific stockholders, and a prospectus of Strive.
A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval. The communication includes forward‑looking statements subject to risks and uncertainties referenced in prior SEC filings of both companies. It also notes that directors, officers, and certain employees of both companies may be deemed participants in the proxy solicitation.
This notice reiterates that it is not an offer or solicitation to sell or buy securities. Investors are urged to read the S‑4 and related materials when available on the SEC’s website and company investor sites.
Strive, Inc. issued a Rule 425 communication regarding its proposed business combination with Semler Scientific. Strive has filed a Form S-4 to register Class A common stock to be issued in connection with the transaction. The registration will include an information statement of Strive, a proxy statement of Semler Scientific, and a prospectus of Strive. A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval.
The communication contains forward-looking statement disclaimers and directs investors to SEC filings for risks and details, including Strive’s S-4 and related reports and Semler Scientific’s 10-K and 10-Qs. It notes that directors and officers of both companies may be deemed participants in the proxy solicitation and provides links to obtain documents free of charge. It also states this is not an offer to sell securities.
Strive, Inc. filed a Rule 425 communication regarding its proposed business combination with Semler Scientific, Inc. (SMLR). Strive has filed a Form S-4 to register Class A common stock to be issued in the transaction, and a combined Information Statement/Proxy Statement/Prospectus will be sent to Semler stockholders to seek their approval.
Investors are directed to review the Registration Statement and related materials when available on the SEC’s website and each company’s investor relations pages. The notice includes standard forward‑looking statement cautions and clarifies this is not an offer or solicitation to buy or sell securities.
Strive, Inc. reposted a communication on X in connection with its proposed business combination with Semler Scientific, Inc. (SMLR). The notice includes a forward‑looking statements caution and explains that Strive has filed a Form S-4 to register Class A common stock to be issued in the transaction.
A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval. The materials will be available free of charge on the SEC’s website and the companies’ investor sites. The communication states it is not an offer or solicitation, and identifies that Strive, Semler Scientific, and certain directors, officers, and employees may be deemed participants in the proxy solicitation for the proposed transaction.
Strive, Inc. filed a Form 425 communication regarding its proposed business combination with Semler Scientific (SMLR). Strive has filed a Registration Statement on Form S-4 to register Class A common stock to be issued in the transaction; the S-4 will include an information statement of Strive, a proxy statement of Semler, and a prospectus of Strive.
A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler stockholders to seek their approval. The materials will be available free on the SEC’s website and the companies’ investor sites. The communication includes forward-looking statement cautions and states it is not an offer or solicitation. Directors, officers, and employees of both companies may be participants in the proxy solicitation, with their interests to be described in the forthcoming proxy/prospectus.
Strive, Inc. filed a Rule 425 communication regarding its proposed business combination with Semler Scientific, Inc. (SMLR). The notice emphasizes forward-looking statement cautions and references Strive’s Form S-4, which registers Class A common stock to be issued in connection with the transaction. A combined Information Statement/Proxy Statement/Prospectus will be provided to Semler Scientific stockholders to seek their approval.
Investors are directed to read the Registration Statement and related materials when available, accessible free of charge on the SEC’s website and each company’s investor relations pages. The communication also notes that directors and officers of both companies may be deemed participants in the proxy solicitation, with their interests to be described in the forthcoming joint materials. It reiterates a standard no offer or solicitation disclaimer, stating that any sale of securities will occur only by means of a prospectus meeting Securities Act requirements.
Strive, Inc. reposted a communication on X regarding its proposed business combination with Semler Scientific. The message emphasizes that any forward-looking statements involve risks and uncertainties.
Strive has filed a Form S‑4 to register Class A common stock to be issued in the transaction, and an Information Statement/Proxy Statement/Prospectus will be sent to Semler stockholders to seek approval. Investors are urged to read the Registration Statement and related materials when available on the SEC website. This communication does not constitute an offer to sell securities.
Strive, Inc. and Semler Scientific announced a proposed business combination. Strive has filed a Form S-4 to register the Class A common stock it would issue in the transaction. The combined information statement, proxy statement, and prospectus will be sent to Semler Scientific stockholders to seek their approval.
The communication includes a standard caution that any forward-looking statements involve risks and uncertainties, and references each company’s SEC filings for additional risk factors. It also notes that directors, officers, and employees of both companies may be deemed participants in the proxy solicitation.
This is not an offer or solicitation to buy or sell securities. Investors can access the Registration Statement and related materials free of charge at the SEC’s website and the companies’ investor relations pages.
Strive, Inc. filed a communication under Rule 425 regarding its proposed business combination with Semler Scientific (SMLR). Strive has filed a Form S-4 to register Class A common stock to be issued in the transaction, which will include an information statement for Strive, a proxy statement for Semler Scientific, and a prospectus for Strive.
A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval. The communication includes forward-looking statement cautions and states it is not an offer or solicitation to buy or sell securities.
Strive, Inc. filed a Rule 425 communication regarding its proposed business combination with Semler Scientific, Inc. (SMLR). The notice reiterates cautionary forward‑looking statements language and directs investors to SEC filings for details.
Strive has filed a Form S-4 to register Class A common stock to be issued in the transaction, which will include a combined Information Statement/Proxy Statement/Prospectus. A definitive version will be sent to Semler stockholders to seek approval of the transaction.
The communication emphasizes that it is not an offer or solicitation and that sales can occur only via a prospectus meeting Section 10 of the Securities Act or an applicable exemption. Investors are urged to read the S‑4 and related materials when available on the SEC’s website and the companies’ investor sites.